Table of Contents
1 Table Of Contents 2
1.1 List of Tables 10
1.2 List of Figures 16
2 Introduction 19
2.1 What Is This Report About? 19
3 Definitions of
Markets Covered in the Report 20
3.1 Cardiovascular Devices 20
3.2
Cardiac Rhythm Management 20
3.3 Cardiovascular monitoring and diagnostic
devices 21
3.4 Cardiovascular prosthetic device 21
3.5 Cardiovascular
Surgery 23
3.6 Electrophysiology 23
3.7 Interventional cardiology
24
3.8 Peripheral vascular devices 25
4 Healthcare Sector Review
27
4.1 Healthcare Expenditure 27
4.2 Healthcare Infrastructure 32
4.3 United States Healthcare Trade Statistics 39
5 Regulation System
40
5.1 Regulation System 40
5.2 Medical Equipment Approval Process
40
18 Pricing and Reimbursement 47
18.1 Government Policies 47
22.1 Private Insurance 48
30.1 Diagnosis Related Groups (DRG) 49
31
Distribution Structure 50
31.1 Distribution Structure 50
32
Cardiovascular Devices In United States 51
32.1 Cardiovascular Devices
Cross Country Comparison (2000-2012) 51
32.2 Cardiovascular Devices,
United States, Overall Revenues ($ mn), 2000-2012 52
32.3 Cardiovascular
Devices, United States, Category Volume (Units), 2000-2012 56
32.4
Cardiovascular Devices, United States Company share (2006-2007) 59
33
Cardiac Rhythm Management In United States 60
33.1 Cardiac Rhythm
Management Overall Revenue (2000-2012) 60
33.2 Cardiac Rhythm Management
Overall Volume (2000-2012) 68
33.3 Cardiac Rhythm Management Average Price
(2000-2012) 76
33.4 Cardiac Rhythm Management Distribution Share
(2006-2007) 77
33.5 Cardiac Rhythm Management, United States, Company
Share (2006-2007) 78
34 Cardiovascular Monitoring and Diagnostic Devices
In United States 79
34.1 Cardiovascular Monitoring and Diagnostic Devices
Overall Revenue (2000-2012) 79
34.2 Cardiovascular Monitoring and
Diagnostic Devices Overall Volume (2000-2012) 82
34.3 Cardiovascular
Monitoring and Diagnostic Devices Average Price (2000-2012) 84
34.4
Cardiovascular Monitoring and Diagnostic Devices Distribution Share
(2006-2007) 85
34.5 Cardiovascular Monitoring and Diagnostic Devices,
United States, Company Share (2006-2007) 86
35 Cardiovascular Prosthetic
Devices In United States 87
35.1 Cardiovascular Prosthetic Devices Overall
Revenue (2000-2012) 87
35.2 Cardiovascular Prosthetic Devices Overall
Volume (2000-2012) 93
35.3 Cardiovascular Prosthetic Devices Average Price
(2000-2012) 98
35.4 Cardiovascular Prosthetic Devices Distribution Share
(2006-2007) 99
35.5 Cardiovascular Prosthetic Devices, United States,
Company Share (2006-2007) 100
36 Cardiovascular Surgery In United States
101
36.1 Cardiovascular Surgery Overall Revenue (2000-2012) 101
36.2
Cardiovascular Surgery Overall Volume (2000-2012) 105
36.3 Cardiovascular
Surgery Average Price (2000-2012) 108
36.4 Cardiovascular Surgery
Distribution Share (2006-2007) 109
36.5 Cardiovascular Surgery, United
States, Company Share (2006-2007) 110
37 Electrophysiology In United
States 111
37.1 Electrophysiology Overall Revenue (2000-2012) 111
37.2
Electrophysiology Overall Volume (2000-2012) 113
37.3 Electrophysiology
Average Price (2000-2012) 114
37.4 Electrophysiology Distribution Share
(2006-2007) 115
37.5 Electrophysiology, United States, Company Share
(2006-2007) 116
38 Interventional Cardiology In United States 117
38.1
Interventional Cardiology Overall Revenue (2000-2012) 117
38.2
Interventional Cardiology Overall Volume (2000-2012) 125
38.3
Interventional Cardiology Average Price (2000-2012) 133
38.4
Interventional Cardiology Distribution Share (2006-2007) 135
38.5
Interventional Cardiology, United States, Company Share (2006-2007) 136
39
Peripheral Vascular Devices In United States 137
39.1 Peripheral Vascular
Devices Overall Revenue (2000-2012) 137
39.2 Peripheral Vascular Devices
Overall Volume (2000-2012) 141
39.3 Peripheral Vascular Devices Average
Price (2000-2012) 143
39.4 Peripheral Vascular Devices Distribution Share
(2006-2007) 144
39.5 Peripheral Vascular Devices, United States, Company
Share (2006-2007) 145
40 Medtronic, Inc. Company Profile 146
40.1
Company Overview 146
40.2 Value Chain Analysis 146
40.3 Medtronic,
Inc. Pipeline Products 149
41 Cordis Corporation Company Profile 157
41.1 Company Overview 157
41.2 Cordis Corporation Pipeline Products
157
42 St. Jude Medical Inc. Company Profile 161
42.1 Company Overview
161
42.2 Value Chain Analysis 161
42.3 St. Jude Medical Inc. Pipeline
Products 164
43 Abbott Laboratories Company Profile 168
43.1 Company
Overview 168
43.2 Value Chain Analysis 168
43.3 Abbott Laboratories
Pipeline Products 171
44 BIOTRONIK GmbH & Co. KG Company Profile 173
44.1 Company Overview 173
44.2 BIOTRONIK GmbH & Co. KG Pipeline Products
173
45 Terumo Corporation Company Profile 175
45.1 Company Overview
175
45.2 Value Chain Analysis 175
45.3 Terumo Corporation Pipeline
Products 177
46 Sorin S.p.A. Strategic Analysis Profile 179
46.1
Company Overview 179
46.2 Value Chain Analysis 179
46.3 Sorin S.p.A.
Pipeline Products 182
47 GE Healthcare Company Profile 186
47.1
Company Overview 186
47.2 GE Healthcare Pipeline Products 186
48
Edwards Lifesciences Corporation Company Profile 189
48.1 Company Overview
189
48.2 Value Chain Analysis 189
48.3 Edwards Lifesciences
Corporation Pipeline Products 192
49 Thoratec Corporation Company Profile
195
49.1 Company Overview 195
49.2 Value Chain Analysis 195
49.3
Thoratec Corporation Pipeline Products 197
50 Arrow International, Inc.
Company Profile 200
50.1 Company Overview 200
50.2 Value Chain
Analysis 200
50.3 Arrow International, Inc. Pipeline Products 202
51
ABIOMED, Inc. Company Profile 204
51.1 Company Overview 204
51.2 Value
Chain Analysis 204
51.3 ABIOMED, Inc. Pipeline Products 206
52
CryoLife, Inc. Company Profile 208
52.1 Company Overview 208
52.2
CryoLife, Inc. Pipeline Products 208
53 LeMaitre Vascular, Inc. Company
Profile 210
53.1 Company Overview 210
53.2 LeMaitre Vascular, Inc.
Pipeline Products 210
54 ACIST Medical Systems, Inc. Company Profile
212
54.1 Company Overview 212
55 Advanced Biosensor, Inc. Company
Profile 213
55.1 Company Overview 213
56 Allvivo Vascular, Inc.
Company Profile 214
56.1 Company Overview 214
57 Angeion Corporation
Company Profile 215
57.1 Company Overview 215
58 AngioDynamics, Inc.
Company Profile 216
58.1 Company Overview 216
59 C.R. Bard, Inc.
Company Profile 217
59.1 Company Overview 217
59.2 Value Chain
Analysis 217
59.3 C.R. Bard, Inc. Pipeline Products 220
60 Cardiac
Science Corporation Company Profile 223
60.1 Company Overview 223
60.2
Value Chain Analysis 223
61 CardioDynamics International Corporation
Company Profile 226
61.1 Company Overview 226
62 CONMED Corporation
Company Profile 227
62.1 Company Overview 227
62.2 Value Chain
Analysis 227
63 Datascope Corporation Company Profile 230
63.1 Company
Overview 230
63.2 Value Chain Analysis 230
63.3 Datascope Corporation
Pipeline Products 233
64 ev3 Inc. Company Profile 234
64.1 Company
Overview 234
64.2 Value Chain Analysis 234
64.3 ev3 Inc. Pipeline
Products 236
65 Hospira, Inc. Company Profile 238
65.1 Company
Overview 238
65.2 Value Chain Analysis 238
66 Philips Medical Systems
Company Profile 241
66.1 Company Overview 241
66.2 VALUE CHAIN
ANALYSIS 241
66.3 Philips Medical Systems Pipeline Products 244
67
Welch Allyn Inc. Company Profile 246
67.1 Company Overview 246
68
Financial Deals Landscape 247
68.1 Detailed Deal Summary 247
69 Recent
Developments 256
69.1 Government and Public Interest 256
69.2 Strategy
and Business Planning 259
69.3 Product News 260
70 Appendix 262
70.1 Global Markets Direct Research Methodology 262
70.2 Coverage 263
70.3 Secondary Research 263
70.4 Primary Research 264
70.5 Models
264
70.6 Forecasts 265
70.7 Expert Panels 265
70.8 Currency
Conversion 266
70.9 Contact Us 267
70.10 Disclaimer 267
List
of Tables
1.1 List of Tables
Table 1: United States Healthcare
Expenditure, 2003-2010 36
Table 2: United States Healthcare Expenditure by
Age (per person), 2000-2003 37
Table 3: United States Healthcare
Expenditure by Sex (per person), 2000-2003 37
Table 4: United States
Healthcare Expenditure by Race (per person), 2000-2003 37
Table 5: United
States Personal Healthcare Expenditure by Type, 2000-2004 38
Table 6:
United States Personal Healthcare Expenditure by Source, 2000-2004 39
Table 7: Total Number of Doctors in the United States, 2003-2010 42
Table
8: Number of Doctors by Specialty in the United States, 2003-2010 43
Table
9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 44
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004
(Cont.) 45
Table 11: Total Hospitals in the United States, 2000-2004
45
Table 12: Community Hospitals by Number of Beds in the United States,
2000-2004 46
Table 13: Number of Hospital Beds in the United States,
2000-2004 46
Table 14: Number of Hospital Beds by Range in the United
States, 2000-2004 46
Table 15: United States Healthcare Trade Statistics,
2001-2006 47
Table 16: Medical Equipment Registration Fee in United
States, 2007 54
Table 17: Medical Device Approval Time in United States,
2004 54
Table 18: Cardiovascular Devices Cross Country Comparison
(2000-2012) 59
Table 19: Cardiovascular Devices, United States,
Overall Revenues ($ mn), 2000-2012 60
Table 20: Cardiovascular Devices
Market, United States, Portfolio Analysis 61
Table 21: Cardiovascular
Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007 62
Table 22: Cardiovascular Devices, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 63
Table 23: Cardiovascular Devices, United
States, Category Volume (Units), 2000-2012 64
Table 24:
Cardiovascular Devices, United States, Category Volume (Units), Historic,
2000-2007 65
Table 25: Cardiovascular Devices, United States,
Category Volume (Units), Forecast, 2007-2012 66
Table 26:
Cardiovascular Devices, United States Company share by Revenue ($ mn),
2006-2007 67
Table 27: Cardiac Rhythm Management, United States,
Revenue ($ mn) by Segment, Historic, 2000-2007 68
Table 28: Cardiac
Rhythm Management, United States, Revenue ($ mn) by Segment, Forecast,
2007-2012 69
Table 29: Cardiac Resynchronisation Therapy, United
States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 70
Table 30:
Cardiac Resynchronisation Therapy, United States, Revenues ($ mn) by
Sub-Segment, Forecast, 2007-2012 71
Table 31: Implantable
Cardioverter Defibrillator, United States, Revenues ($ mn) by Sub-Segment,
Historic, 2000-2007 72
Table 32: Implantable Cardioverter
Defibrillator, United States, Revenues ($ mn) by Sub-Segment, Forecast,
2007-2012 73
Table 33: Pacemaker, United States, Revenues ($ mn) by
Sub-Segment, Historic, 2000-2007 74
Table 34: Pacemaker, United
States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 75
Table 35:
Cardiac Rhythm Management, United States, Overall Volume (Units), Historic,
2000-2007 76
Table 36: Cardiac Rhythm Management, United States,
Overall Volume (Units), Forecast, 2007-2012 77
Table 37: Cardiac
Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2007 78
Table 38: Cardiac Resynchronisation Therapy,
United States, Volume (Units) by Sub-Segment, Forecast, 2007-2012 79
Table
39: Implantable Cardioverter Defibrillator, United States, Volume (Units)
by Sub-Segment, Historic, 2000-2007 80
Table 40: Implantable
Cardioverter Defibrillator, United States, Volume (Units) by Sub-Segment,
Forecast, 2007-2012 81
Table 41: Pacemaker, United States, Volume
(Units) by Sub-Segment, Historic, 2000-2007 82
Table 42: Pacemaker,
United States, Volume (Units) by Sub-Segment, Forecast, 2007-2012 83
Table
43: Cardiac Rhythm Management, United States, Average Price ($),
Historic, 2000-2007 84
Table 44: Cardiac Rhythm Management, United
States, Average Price ($), Forecast, 2007-2012 84
Table 45: Cardiac
Rhythm Management, United States, Distribution Share by Revenue ($mn),
2006-2007 85
Table 46: Cardiac Rhythm Management, United States,
Company Share by Revenue ($ mn), 2006-2007 86
Table 47:
Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($
mn) by Segment, Historic, 2000-2007 88
Table 48: Cardiovascular
Monitoring and Diagnostic Devices, United States, Revenue ($ mn) by Segment,
Forecast, 2007-2012 89
Table 49: Cardiovascular Monitoring and
Diagnostic Devices, United States, Overall Volume (Units), Historic, 2000-2007
90
Table 50: Cardiovascular Monitoring and Diagnostic Devices, United
States, Overall Volume (Units), Forecast, 2007-2012 91
Table 51:
Cardiovascular Monitoring and Diagnostic Devices, United States, Average Price
($), Historic, 2000-2007 92
Table 52: Cardiovascular Monitoring and
Diagnostic Devices, United States, Average Price ($), Forecast, 2007-2012
92
Table 53: Cardiovascular Monitoring and Diagnostic Devices, United
States, Distribution Share by Revenue ($mn), 2006-2007 93
Table 54:
Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share
by Revenue ($ mn), 2006-2007 94
Table 55: Cardiovascular Prosthetic
Devices, United States, Revenue ($ mn) by Segment, Historic, 2000-2007 95
Table 56: Cardiovascular Prosthetic Devices, United States, Revenue ($
mn) by Segment, Forecast, 2007-2012 96
Table 57: Cardiac Assist
Devices, United States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
97
Table 58: Cardiac Assist Devices, United States, Revenues ($ mn)
by Sub-Segment, Forecast, 2007-2012 98
Table 59: Prosthetic Heart
Valve, United States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
99
Table 60: Prosthetic Heart Valve, United States, Revenues ($ mn)
by Sub-Segment, Forecast, 2007-2012 100
Table 61: Cardiovascular
Prosthetic Devices, United States, Overall Volume (Units), Historic, 2000-2007
101
Table 62: Cardiovascular Prosthetic Devices, United States,
Overall Volume (Units), Forecast, 2007-2012 102
Table 63: Cardiac
Assist Devices, United States, Volume (Units) by Sub-Segment, Historic,
2000-2007 103
Table 64: Cardiac Assist Devices, United States, Volume
(Units) by Sub-Segment, Forecast, 2007-2012 103
Table 65: Prosthetic
Heart Valve, United States, Volume (Units) by Sub-Segment, Historic, 2000-2007
104
Table 66: Prosthetic Heart Valve, United States, Volume (Units)
by Sub-Segment, Forecast, 2007-2012 105
Table 67: Cardiovascular
Prosthetic Devices, United States, Average Price ($), Historic, 2000-2007
106
Table 68: Cardiovascular Prosthetic Devices, United States,
Average Price ($), Forecast, 2007-2012 106
Table 69: Cardiovascular
Prosthetic Devices, United States, Distribution Share by Revenue ($mn),
2006-2007 107
Table 70: Cardiovascular Prosthetic Devices, United
States, Company Share by Revenue ($ mn), 2006-2007 108
Table 71:
Cardiovascular Surgery, United States, Revenue ($ mn) by Segment, Historic,
2000-2007 109
Table 72: Cardiovascular Surgery, United States,
Revenue ($ mn) by Segment, Forecast, 2007-2012 110
Table 73:
Perfusion Disposables, United States, Revenues ($ mn) by Sub-Segment,
Historic, 2000-2007 111
Table 74: Perfusion Disposables, United
States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 112
Table 75:
Cardiovascular Surgery, United States, Overall Volume (Units), Historic,
2000-2007 113
Table 76: Cardiovascular Surgery, United States,
Overall Volume (Units), Forecast, 2007-2012 113
Table 77: Perfusion
Disposables, United States, Volume (Units) by Sub-Segment, Historic, 2000-2007
114
Table 78: Perfusion Disposables, United States, Volume (Units) by
Sub-Segment, Forecast, 2007-2012 115
Table 79: Cardiovascular
Surgery, United States, Average Price ($), Historic, 2000-2007 116
Table
80: Cardiovascular Surgery, United States, Average Price ($), Forecast,
2007-2012 116
Table 81: Cardiovascular Surgery, United States,
Distribution Share by Revenue ($mn), 2006-2007 117
Table 82:
Cardiovascular Surgery, United States, Company Share by Revenue ($ mn),
2006-2007 118
Table 83: Electrophysiology, United States, Revenue ($
mn) by Segment, Historic, 2000-2007 119
Table 84: Electrophysiology,
United States, Revenue ($ mn) by Segment, Forecast, 2007-2012 120
Table
85: Electrophysiology, United States, Overall Volume (Units), Historic,
2000-2007 121
Table 86: Electrophysiology, United States, Overall
Volume (Units), Forecast, 2007-2012 121
Table 87: Electrophysiology,
United States, Average Price ($), Historic, 2000-2007 122
Table 88:
Electrophysiology, United States, Average Price ($), Forecast, 2007-2012
122
Table 89: Electrophysiology, United States, Distribution Share by
Revenue ($ mn), 2006-2007 123
Table 90: Electrophysiology, United
States, Company Share by Revenue ($ mn), 2006-2007 124
Table 91:
Interventional Cardiology, United States, Revenue ($ mn) by Segment, Historic,
2000-2007 125
Table 92: Interventional Cardiology, United States,
Revenue ($ mn) by Segment, Forecast, 2007-2012 126
Table 93: Cardiac
Catheter, United States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
127
Table 94: Cardiac Catheter, United States, Revenues ($ mn) by
Sub-Segment, Forecast, 2007-2012 128
Table 95: Coronary Stent, United
States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 129
Table 96:
Coronary Stent, United States, Revenues ($ mn) by Sub-Segment, Forecast,
2007-2012 130
Table 97: PTCA Balloon, United States, Revenues ($ mn)
by Sub-Segment, Historic, 2000-2007 131
Table 98: PTCA Balloon,
United States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 132
Table 99: Interventional Cardiology, United States, Overall Volume
(Units), Historic, 2000-2007 133
Table 100: Interventional
Cardiology, United States, Overall Volume (Units), Forecast, 2007-2012 134
Table 101: Cardiac Catheter, United States, Volume (Units) by
Sub-Segment, Historic, 2000-2007 135
Table 102: Cardiac Catheter,
United States, Volume (Units) by Sub-Segment, Forecast, 2007-2012 136
Table 103: Coronary Stent, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2007 137
Table 104: Coronary Stent, United States,
Volume (Units) by Sub-Segment, Forecast, 2007-2012 138
Table 105:
PTCA Balloon, United States, Volume (Units) by Sub-Segment, Historic,
2000-2007 139
Table 106: PTCA Balloon, United States, Volume (Units)
by Sub-Segment, Forecast, 2007-2012 140
Table 107: Interventional
Cardiology, United States, Average Price ($), Historic, 2000-2007 141
Table 108: Interventional Cardiology, United States, Average Price ($),
Forecast, 2007-2012 142
Table 109: Interventional Cardiology, United
States, Distribution Share by Revenue ($mn), 2006-2007 143
Table 110:
Interventional Cardiology, United States, Company Share by Revenue ($ mn),
2006-2007 144
Table 111: Peripheral Vascular Devices, United States,
Revenue ($ mn) by Segment, Historic, 2000-2007 146
Table 112:
Peripheral Vascular Devices, United States, Revenue ($ mn) by Segment,
Forecast, 2007-2012 148
Table 113: Peripheral Vascular Devices,
United States, Overall Volume (Units), Historic, 2000-2007 149
Table 114:
Peripheral Vascular Devices, United States, Overall Volume (Units),
Forecast, 2007-2012 150
Table 115: Peripheral Vascular Devices,
United States, Average Price ($), Historic, 2000-2007 151
Table 116:
Peripheral Vascular Devices, United States, Average Price ($), Forecast,
2007-2012 151
Table 117: Peripheral Vascular Devices, United States,
Distribution Share by Revenue ($mn), 2006-2007 152
Table 118:
Peripheral Vascular Devices, United States, Company Share by Revenue ($ mn),
2006-2007 153
Table 119: Medtronic, Inc. Pipeline Products by
Equipment Type 157
Table 120: Medtronic, Inc. Pipeline Products By
Development Stage 159
Table 121: Medtronic, Inc. Pipeline Products By
Therapy Area 161
Table 122: Medtronic, Inc. Pipeline Products By
Clinical Trials 163
Table 123: Medtronic, Inc. Pipeline Products By
News Summaries 164
Table 124: Cordis Corporation Pipeline Products by
Equipment Type 165
Table 125: Cordis Corporation Pipeline Products By
Development Stage 165
Table 126: Cordis Corporation Pipeline Products
By Therapy Area 166
Table 127: Cordis Corporation Pipeline Products
By Clinical Trials 166
Table 128: Cordis Corporation Pipeline
Products By News Summaries 167
Table 129: St. Jude Medical Inc.
Pipeline Products by Equipment Type 172
Table 130: St. Jude Medical
Inc. Pipeline Products By Development Stage 173
Table 131: St. Jude
Medical Inc. Pipeline Products By Therapy Area 174
Table 132: St.
Jude Medical Inc. Pipeline Products By Clinical Trials 174
Table 133:
St. Jude Medical Inc. Pipeline Products By News Summaries 175
Table 134:
Abbott Laboratories Pipeline Products by Equipment Type 179
Table 135:
Abbott Laboratories Pipeline Products By Development Stage 179
Table
136: Abbott Laboratories Pipeline Products By Therapy Area 179
Table
137: Abbott Laboratories Pipeline Products By Clinical Trials 179
Table 138: Abbott Laboratories Pipeline Products By News Summaries
180
Table 139: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment
Type 181
Table 140: BIOTRONIK GmbH & Co. KG Pipeline Products By
Development Stage 181
Table 141: BIOTRONIK GmbH & Co. KG Pipeline
Products By Therapy Area 182
Table 142: BIOTRONIK GmbH & Co. KG
Pipeline Products By Clinical Trials 182
Table 143: BIOTRONIK GmbH &
Co. KG Pipeline Products By News Summaries 182
Table 144: Terumo
Corporation Pipeline Products by Equipment Type 185
Table 145: Terumo
Corporation Pipeline Products By Development Stage 185
Table 146:
Terumo Corporation Pipeline Products By Therapy Area 185
Table 147:
Terumo Corporation Pipeline Products By Clinical Trials 186
Table 148:
Terumo Corporation Pipeline Products By News Summaries 186
Table 149:
Sorin S.p.A. Pipeline Products by Equipment Type 190
Table 150:
Sorin S.p.A. Pipeline Products By Development Stage 191
Table 151:
Sorin S.p.A. Pipeline Products By Therapy Area 192
Table 152: Sorin
S.p.A. Pipeline Products By Clinical Trials 193
Table 153: Sorin
S.p.A. Pipeline Products By News Summaries 193
Table 154: GE
Healthcare Pipeline Products by Equipment Type 194
Table 155: GE
Healthcare Pipeline Products By Development Stage 195
Table 156: GE
Healthcare Pipeline Products By Therapy Area 195
Table 157: GE
Healthcare Pipeline Products By Clinical Trials 195
Table 158: GE
Healthcare Pipeline Products By News Summaries 196
Table 159: Edwards
Lifesciences Corporation Pipeline Products by Equipment Type 200
Table
160: Edwards Lifesciences Corporation Pipeline Products By Development
Stage 200
Table 161: Edwards Lifesciences Corporation Pipeline
Products By Therapy Area 201
Table 162: Edwards Lifesciences
Corporation Pipeline Products By Clinical Trials 201
Table 163:
Edwards Lifesciences Corporation Pipeline Products By News Summaries 202
Table 165: Thoratec Corporation Pipeline Products by Equipment Type
205
Table 166: Thoratec Corporation Pipeline Products By Development
Stage 205
Table 167: Thoratec Corporation Pipeline Products By
Therapy Area 206
Table 168: Thoratec Corporation Pipeline Products By
Clinical Trials 206
Table 169: Thoratec Corporation Pipeline Products
By News Summaries 206
Table 171: Arrow International, Inc. Pipeline
Products by Equipment Type 210
Table 172: Arrow International, Inc.
Pipeline Products By Development Stage 210
Table 173: Arrow
International, Inc. Pipeline Products By Therapy Area 211
Table 174:
Arrow International, Inc. Pipeline Products By Clinical Trials 211
Table
175: ABIOMED, Inc. Pipeline Products by Equipment Type 214
Table 176:
ABIOMED, Inc. Pipeline Products By Development Stage 214
Table 177:
ABIOMED, Inc. Pipeline Products By Therapy Area 214
Table 178:
ABIOMED, Inc. Pipeline Products By Clinical Trials 215
Table 179:
ABIOMED, Inc. Pipeline Products By News Summaries 215
Table 180:
CryoLife, Inc. Pipeline Products by Equipment Type 216
Table 181:
CryoLife, Inc. Pipeline Products By Development Stage 216
Table 182:
CryoLife, Inc. Pipeline Products By Therapy Area 217
Table 183:
CryoLife, Inc. Pipeline Products By Clinical Trials 217
Table 184:
CryoLife, Inc. Pipeline Products By News Summaries 217
Table 185:
LeMaitre Vascular, Inc. Pipeline Products by Equipment Type 218
Table 186:
LeMaitre Vascular, Inc. Pipeline Products By Development Stage 218
Table 187: LeMaitre Vascular, Inc. Pipeline Products By Therapy Area
219
Table 188: LeMaitre Vascular, Inc. Pipeline Products By Clinical
Trials 219
Table 189: LeMaitre Vascular, Inc. Pipeline Products By
News Summaries 219
Table 190: C.R. Bard, Inc. Pipeline Products by
Equipment Type 228
Table 191: C.R. Bard, Inc. Pipeline Products By
Development Stage 228
Table 192: C.R. Bard, Inc. Pipeline Products By
Therapy Area 229
Table 193: C.R. Bard, Inc. Pipeline Products By
Clinical Trials 229
Table 194: C.R. Bard, Inc. Pipeline Products By
News Summaries 230
Table 195: Datascope Corporation Pipeline Products
by Equipment Type 241
Table 196: Datascope Corporation Pipeline
Products By Development Stage 241
Table 197: Datascope Corporation
Pipeline Products By Therapy Area 241
Table 198: Datascope
Corporation Pipeline Products By News Summaries 241
Table 199: ev3
Inc. Pipeline Products by Equipment Type 244
Table 200: ev3 Inc.
Pipeline Products By Development Stage 244
Table 201: ev3 Inc.
Pipeline Products By Therapy Area 245
Table 202: ev3 Inc. Pipeline
Products By Clinical Trials 245
Table 203: ev3 Inc. Pipeline Products
By News Summaries 245
Table 205: Philips Medical Systems Pipeline
Products by Equipment Type 252
Table 206: Philips Medical Systems
Pipeline Products By Development Stage 252
Table 207: Philips Medical
Systems Pipeline Products By Therapy Area 252
Table 208: Philips
Medical Systems Pipeline Products By Clinical Trials 253
Table 209:
Philips Medical Systems Pipeline Products By News Summaries 253
Table 210:
SAES Getters Acquires Memry, An Orthopedic Vendor 255
Table 211:
Getinge To Acquire Datascope 257
Table 212: Curtiss-Wright Acquires
Parylene Coating Services 259
Table 213: Welch Allyn And ZOLL Medical
Form Partnership 260
Table 214: Elixir Medical Enters Into An
Agreement With Novartis Pharma 261
Table 215: OmniSonics Medical
Technologies Enters Into An Agreement With Boston Scientific 262
Table
216: Syntermed Enters Into An Agreement With Emory University 263
Table 217: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 274
List of Figures
1.2 List of Figures
Figure 1: United
States, Healthcare Expenditure by Source, 2003 36
Figure 2: United States,
Healthcare Infrastructure, Top Level View, 2007 41
Figure 3: Healthcare
Expenses Segmentation by End User, 2003 42
Figure 4: Medical Equipment
Approval Process in the United States, 2007 49
Figure 5: PMA Approval
Process in the United States, 2007 51
Figure 6: The 510(k) Approval
Process for Medical Devices in the United States, 2007 52
Figure 7:
Reimbursement Structure in the United States, 2007 57
Figure 8:
Distribution Structure of Medical Equipment in the United States, 2006 58
Figure 9: Cardiovascular Devices Cross Country Comparison (2000-2012)
59
Figure 10: Cardiovascular Devices, United States, Overall Revenues
($ mn), 2000-2012 60
Figure 11: Cardiovascular Devices Market, United
States, Portfolio Analysis 61
Figure 12: Cardiovascular Devices,
United States, Overall Revenues ($ mn), Historic, 2000-2007 62
Figure 13:
Cardiovascular Devices, United States, Overall Revenues ($ mn), Forecast,
2007-2012 63
Figure 14: Cardiovascular Devices, United States,
Category Volume (Units), 2000-2012 64
Figure 15: Cardiovascular
Devices, United States, Category Volume (Units), Historic, 2000-2007 65
Figure 16: Cardiovascular Devices, United States, Category Volume
(Units), Forecast, 2007-2012 66
Figure 17: Cardiovascular Devices,
United States Company share (%), 2007 67
Figure 18: Cardiac Rhythm
Management, United States, Revenue ($ mn) by Segment, Historic, 2000-2007
68
Figure 19: Cardiac Rhythm Management, United States, Revenue ($
mn) by Segment, Forecast, 2007-2012 69
Figure 20: Cardiac
Resynchronisation Therapy, United States, Revenues ($ mn) by Sub-Segment,
Historic, 2000-2007 70
Figure 21: Cardiac Resynchronisation Therapy,
United States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 71
Figure 22: Implantable Cardioverter Defibrillator, United States,
Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 72
Figure 23:
Implantable Cardioverter Defibrillator, United States, Revenues ($ mn) by
Sub-Segment, Forecast, 2007-2012 73
Figure 24: Pacemaker, United
States, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 74
Figure 25:
Pacemaker, United States, Revenues ($ mn) by Sub-Segment, Forecast,
2007-2012 75
Figure 26: Cardiac Rhythm Management, United States,
Overall Volume (Units), Historic, 2000-2007 76
Figure 27: Cardiac
Rhythm Management, United States, Overall Volume (Units), Forecast, 2007-2012
77
Figure 28: Cardiac Resynchronisation Therapy, United States,
Volume (Units) by Sub-Segment, Historic, 2000-2007 78
Figure 29:
Cardiac Resynchronisation Therapy, United States, Volume (Units) by
Sub-Segment, Forecast, 2007-2012 79
Figure 30: Implantable
Cardioverter Defibrillator, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2007 80
Figure 31: Implantable Cardioverter
Defibrillator, United States, Volume (Units) by Sub-Segment, Forecast,
2007-2012 81
Figure 32: Pacemaker, United States, Volume (Units) by
Sub-Segment, Historic, 2000-2007 82
Figure 33: Pacemaker, United
States, Volume (Units) by Sub-Segment, Forecast, 2007-2012 83
Figure 34:
Cardiac Rhythm Management, United States, Company Share (%), 2007 86
Figure 35: Cardiovascular Monitoring and Diagnostic Devices, United
States, Revenue ($ mn) by Segment, Historic, 2000-2007 87
Figure 36:
Cardiovascular Monitoring and Diagnostic Devices, United States, Revenue ($
mn) by Segment, Forecast, 2007-2012 89
Figure 37: Cardiovascular
Monitoring and Diagnostic Devices, United States, Overall Volume (Units),
Historic, 2000-2007 90
Figure 38: Cardiovascular Monitoring and
Diagnostic Devices, United States, Overall Volume (Units), Forecast, 2007-2012
91
Figure 39: Cardiovascular Monitoring and Diagnostic Devices,
United States, Company Share (%), 2007 94
Figure 40: Cardiovascular
Prosthetic Devices, United States, Revenue ($ mn) by Segment, Historic,
2000-2007 95
Figure 41: Cardiovascular Prosthetic Devices, United
States, Revenue ($ mn) by Segment, Forecast, 2007-2012 96
Figure 42:
Cardiac Assist Devices, United States, Revenues ($ mn) by Sub-Segment,
Historic, 2000-2007 97
Figure 43: Cardiac Assist Devices, United
States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 98
Figure 44:
Prosthetic Heart Valve, United States, Revenues ($ mn) by Sub-Segment,
Historic, 2000-2007 99
Figure 45: Prosthetic Heart Valve, United
States, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 100
Figure 46:
Cardiovascular Prosthetic Devices, United States, Overall Volume (Units),
Historic, 2000-2007 101
Figure 47: Cardiovascular Prosthetic Devices,
United States, Overall Volume (Units), Forecast, 2007-2012 102
Figure 48:
Prosthetic Heart Valve, United States, Volume (Units) by Sub-Segment,
Historic, 2000-2007 104
Figure 49: Prosthetic Heart Valve, United
States, Volume (Units) by Sub-Segment, Forecast, 2007-2012 105
Figure 50:
Cardiovascular Prosthetic Devices, United States, Company Share (%), 2007
108
Figure 51: Cardiovascular Surgery, United States, Revenue ($ mn)
by Segment, Historic, 2000-2007 109
Figure 52: Cardiovascular
Surgery, United States, Revenue ($ mn) by Segment, Forecast, 2007-2012 110
Figure 53: Perfusion Disposables, United States, Revenues ($ mn) by
Sub-Segment, Historic, 2000-2007 111
Figure 54: Perfusion
Disposables, United States, Revenues ($ mn) by Sub-Segment, Forecast,
2007-2012 112
Figure 55: Perfusion Disposables, United States, Volume
(Units) by Sub-Segm
|
Related Report
|
View Cart
